Offer - Urjas Oil for just ₹ 1 X
Esiflo 250 Transcaps is a commercial drug that is prescribed in the form of Transcaps. Other than this, Esiflo 250 Transcaps has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Esiflo 250 Transcaps depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Esiflo 250 Transcaps include Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Esiflo 250 Transcaps as well, which are listed below. Normally, these side effects of Esiflo 250 Transcaps are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Esiflo 250 Transcaps is Moderate for pregnant women and Mild for women who are breastfeeding. Further, the section on Esiflo 250 Transcaps related warnings talks about Esiflo 250 Transcaps's effects on the liver, heart and kidney.
Other contraindications of Esiflo 250 Transcaps have been discussed in the sections ahead.
Additionally, Esiflo 250 Transcaps may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Esiflo 250 Transcaps, it is important to know that it is safe while driving, and is habit-forming.
Esiflo 250 Transcaps is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Esiflo 250 Transcaps safe for pregnant women?
Pregnant women may experience moderate side effects from Esiflo. It is best to stop taking Esiflo immediately and inform your doctor if you notice any discomfort.
Is the use of Esiflo 250 Transcaps safe during breastfeeding?
Esiflo may have very limited harmful effects for breastfeeding women.
What is the effect of Esiflo 250 Transcaps on the Kidneys?
Esiflo is not harmful for kidneys.
What is the effect of Esiflo 250 Transcaps on the Liver?
You may experience side effects on your liver after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Esiflo 250 Transcaps on the Heart?
You may experience side effects on your heart after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Esiflo 250 Transcaps should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esiflo 250 Transcaps unless your doctor advises you to do so -
Is this Esiflo 250 Transcaps habit forming or addictive?
No, you will not get addicted to Esiflo 250 Transcaps.
Interaction between Food and Esiflo 250 Transcaps
There isn't any research available on the side effects of taking Esiflo 250 Transcaps with food.
Interaction between Alcohol and Esiflo 250 Transcaps
No research has been done on this till date. Therefore, it is not known what the effect of taking Esiflo 250 Transcaps with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359